A randomized phase II trial of irinotecan plus oxaliplatin versus oxaliplatin, fluorouracil (5 FU), leukovorin (LV) as first-line treatment in advanced gastric cancer

被引：0
|
作者：
Boukovinas, I. [1 ]
Androulakis, N. [1 ]
Polyzos, A. [1 ]
Vardakis, N. [1 ]
Amarantidis, K. [1 ]
Bozionelou, V. [1 ]
Kouroussis, C. [1 ]
Giassas, S. [1 ]
Christophyllakis, C. [1 ]
Mavroudis, D. [1 ]
机构：
[1] Hellen Oncol Res Grp, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4536
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer
    Scheithauer, W
    Kornek, GV
    Raderer, M
    Ulrich-Pur, H
    Fiebiger, W
    Gedlicka, C
    Schüll, B
    Brugger, S
    Schneeweiss, B
    Lang, F
    Lenauer, A
    Depisch, D
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) : 165 - 172
  • [2] Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer
    Cao, Weiguo
    Yang, Weiping
    Lou, Guying
    Jiang, Jinsong
    Geng, Mei
    Xi, Wenqi
    Li, Hao
    Ma, Tao
    Jin, Yening
    ANTI-CANCER DRUGS, 2009, 20 (04) : 287 - 293
  • [3] Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer
    von Weikersthal, Ludwig Fischer
    Schalhorn, Andreas
    Stauch, Martina
    Quietzsch, Detlef
    Maubach, Peter A.
    Lambertz, Helmut
    Oruzio, Daniel
    Schlag, Rudolf
    Weigang-Koehler, Karin
    Vehling-Kaiser, Ute
    Schulze, Manfred
    Truckenbrodt, Juergen
    Goebeler, Mariele
    Mittermueller, Johann
    Bosse, Daniel
    Szukics, Borika
    Grundeis, Marc
    Zwingers, Thomas
    Giessen, Clemens
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (02) : 206 - 214
  • [4] 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer
    Grande, C.
    Martinez, M.
    Villanueva, M. J.
    Huidobro, G.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S469 - S469
  • [5] Phase II trial of oxaliplatin plus capecitabine as first-line treatment in patients with advanced gastric cancer (AGC)
    Palumbo, R.
    Bernardo, A.
    Strada, M. R.
    Poggi, G.
    Teragni, C.
    Delmonte, A.
    Frascaroli, M.
    Jedrychowska, I
    Canto, A. M.
    Bernardo, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI51 - XI52
  • [6] Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
    Kalofonos, HP
    Aravantinos, G
    Kosmidis, P
    Papakostas, P
    Economopoulos, T
    Dimopoulos, M
    Skarlos, D
    Bamias, A
    Pectasides, D
    Chalkidou, S
    Karina, M
    Koutras, A
    Samantas, E
    Bacoyiannis, C
    Samelis, GF
    Basdanis, G
    Kalfarentzos, F
    Fountzilas, G
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 869 - 877
  • [7] Phase IIb trial of fluorouracil, leucovorin, oxaliplatin, and paclitaxel (POF) compared with fluorouracil, feucovorin, and irinotecan (IF) as first-line treatment for advanced gastric cancer (AGC)
    Lin, R.
    Chen, Q.
    Fan, N.
    Ye, Y.
    Guo, Z.
    Wang, X.
    Liu, J.
    Chen, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] First-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4) Versus 5-FU/LV (de Gramont Regimen)
    Schinzari, Giovanni
    Rossi, Ernesto
    Mambella, Giuseppina
    Strippoli, Antonia
    Cangiano, Rodolfo
    Mutignani, Massimiliano
    Basso, Michele
    Cassano, Alessandra
    Barone, Carlo
    ANTICANCER RESEARCH, 2017, 37 (09) : 5193 - 5197
  • [9] Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
    Punt, CJA
    ANNALS OF ONCOLOGY, 2005, 16 (06) : 845 - 846
  • [10] Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer
    Yang, Tingsong
    Shen, Xiaojun
    Tang, Xiaojun
    Wei, Guo
    Zhang, Hao
    Du, Chenghui
    Xue, Xuchao
    Ma, Liye
    Nie, Mingming
    Bi, Jianwei
    TUMORI, 2011, 97 (04) : 466 - 472
12345